Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Geiger

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Cancers|April 23, 2022
Identification of TPM2 and CNN1 as Novel Prognostic Markers in Functionally Characterized Human Colon Cancer-Associated Stromal CellsValentina Mele, Camilla Basso, Valeria Governa, et al.
Nature|October 7, 2021
Metabolic modulation of tumours with engineered bacteria for immunotherapyFernando P Canale, Camilla Basso, Gaia Antonini, et al.
Nature Communications|August 6, 2024
Epigenome-wide impact of MAT2A sustains the androgen-indifferent state and confers synthetic vulnerability in ERG fusion-positive prostate cancerAlessia Cacciatore, Dheeraj Shinde, Carola Musumeci, et al.
Nature Microbiology|August 31, 2016
Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimerAnna Kabanova, Jessica Marcandalli, Tongqing Zhou, et al.
Nature Immunology|July 8, 2020
Dynamics in protein translation sustaining T cell preparednessTobias Wolf, Wenjie Jin, Giada Zoppi, et al.
Nature Cancer|June 3, 2024
Tumor-associated macrophages restrict CD8<sup>+</sup> T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironmentKevin M Tharp, Kelly Kersten, Ori Maller, et al.
Nature Medicine|September 11, 2019
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patientsAntonino Cassotta, Vincent Mikol, Thomas Bertrand, et al.
Nature|December 25, 2015
A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigensJoshua Tan, Kathrin Pieper, Luca Piccoli, et al.
Oncogene|September 2, 2025
Integrated control of cancer stemness by σ<sub>1</sub> receptor in advanced prostate cancerGianluca Civenni, Giada Sandrini, Jessica Merulla, et al.
The Journal of Allergy and Clinical Immunology|August 8, 2017
Plasma cell deficiency in human subjects with heterozygous mutations in Sec61 translocon alpha 1 subunit (SEC61A1)Desirée Schubert, Marie-Christine Klein, Sarah Hassdenteufel, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cancers|April 23, 2022
Identification of TPM2 and CNN1 as Novel Prognostic Markers in Functionally Characterized Human Colon Cancer-Associated Stromal CellsValentina Mele, Camilla Basso, Valeria Governa, et al.
Nature|October 7, 2021
Metabolic modulation of tumours with engineered bacteria for immunotherapyFernando P Canale, Camilla Basso, Gaia Antonini, et al.
Nature Communications|August 6, 2024
Epigenome-wide impact of MAT2A sustains the androgen-indifferent state and confers synthetic vulnerability in ERG fusion-positive prostate cancerAlessia Cacciatore, Dheeraj Shinde, Carola Musumeci, et al.
Nature Microbiology|August 31, 2016
Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimerAnna Kabanova, Jessica Marcandalli, Tongqing Zhou, et al.
Nature Immunology|July 8, 2020
Dynamics in protein translation sustaining T cell preparednessTobias Wolf, Wenjie Jin, Giada Zoppi, et al.
Nature Cancer|June 3, 2024
Tumor-associated macrophages restrict CD8<sup>+</sup> T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironmentKevin M Tharp, Kelly Kersten, Ori Maller, et al.
Nature Medicine|September 11, 2019
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patientsAntonino Cassotta, Vincent Mikol, Thomas Bertrand, et al.
Nature|December 25, 2015
A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigensJoshua Tan, Kathrin Pieper, Luca Piccoli, et al.
Oncogene|September 2, 2025
Integrated control of cancer stemness by σ<sub>1</sub> receptor in advanced prostate cancerGianluca Civenni, Giada Sandrini, Jessica Merulla, et al.
The Journal of Allergy and Clinical Immunology|August 8, 2017
Plasma cell deficiency in human subjects with heterozygous mutations in Sec61 translocon alpha 1 subunit (SEC61A1)Desirée Schubert, Marie-Christine Klein, Sarah Hassdenteufel, et al.
Pageof 4